| IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer H Yousefi, M Momeny, SH Ghaffari, N Parsanejad, A Poursheikhani, ... Tumori journal 105 (1), 84-91, 2019 | 36 | 2019 |
| Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells M Momeny, F Moghaddaskho, NK Gortany, H Yousefi, Z Sabourinejad, ... Scientific Reports 7 (1), 44075, 2017 | 34 | 2017 |
| Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells M Momeny, H Yousefi, H Eyvani, F Moghaddaskho, A Salehi, F Esmaeili, ... The international journal of biochemistry & cell biology 99, 1-9, 2018 | 33 | 2018 |
| CRISPR-Cas9-edited tacrolimus-resistant antiviral T cells for advanced adoptive immunotherapy in transplant recipients L Amini, DL Wagner, U Rössler, G Zarrinrad, LF Wagner, T Vollmer, ... Molecular Therapy 29 (1), 32-46, 2021 | 32 | 2021 |
| Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells M Momeny, Z Sabourinejad, G Zarrinrad, F Moghaddaskho, H Eyvani, ... Scientific reports 7 (1), 45954, 2017 | 32 | 2017 |
| Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells M Momeny, G Zarrinrad, F Moghaddaskho, A Poursheikhani, ... Scientific Reports 7 (1), 4204, 2017 | 30 | 2017 |
| The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes H Fasehee, G Zarrinrad, SM Tavangar, SH Ghaffari, S Faghihi Materials Science and Engineering: C 63, 587-595, 2016 | 29 | 2016 |
| Thalidomide attenuates development of morphine dependence in mice by inhibiting PI3K/Akt and nitric oxide signaling pathways MI Khan, M Momeny, S Ostadhadi, S Jahanabadi, S Ejtemaei-Mehr, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, 39-48, 2018 | 21 | 2018 |
| NMDA receptor antagonists attenuate the proconvulsant effect of juvenile social isolation in male mice S Amiri, A Haj-Mirzaian, H Amini-khoei, M Momeny, A Shirzadian, ... Brain Research Bulletin 121, 158-168, 2016 | 21 | 2016 |
| Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway M Momeny, R Ghasemi, G Valenti, M Miranda, A Zekri, G Zarrinrad, ... Tumor Biology 37, 3913-3923, 2016 | 18 | 2016 |
| Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo D Kaiser, NM Otto, O McCallion, H Hoffmann, G Zarrinrad, M Stein, ... Frontiers in Cell and Developmental Biology 9, 750286, 2021 | 14 | 2021 |
| Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients L Peter, DJ Wendering, S Schlickeiser, H Hoffmann, R Noster, DL Wagner, ... Molecular Therapy-Methods & Clinical Development 25, 52-73, 2022 | 12 | 2022 |
| Strong expansion of human regulatory T cells for adoptive cell therapy results in epigenetic changes which may impact their survival and function K Ou, D Hamo, A Schulze, A Roemhild, D Kaiser, G Gasparoni, A Salhab, ... Frontiers in Cell and Developmental Biology 9, 751590, 2021 | 12 | 2021 |
| Pharmacological evidence for the involvement of adenosine triphosphate sensitive potassium channels in chloroquine-induced itch in mice S Ostadhadi, A Foroutan, NS Haddadi, A Norouzi-Javidan, M Momeny, ... Pharmacological Reports 69 (6), 1295-1299, 2017 | 9 | 2017 |
| ADAPTING ANTIVIRAL AND REGULATORY T CELL PRODUCTS FOR USE IN THE TRANSPLANTATION SETTING: RESISTANCE TO TACROLIMUS ACHIEVED BY A GMP-GRADE CRISPR/CAS9 TECHNOLOGY APPROACH L Amini, LM Burkhardt, A Roemhild, D Kaiser, G Zarrinrad, N Wiese, ... HUMAN GENE THERAPY 34 (21-22), A13-A14, 2023 | | 2023 |
| A NOVEL GENE-EDITED REGULATORY T CELL PRODUCT RESISTANT TO TACROLIMUS G Zarrinrad, D Wendering, S Schlickeiser, L Peter, S Schulenberg, S Picht, ... HUMAN GENE THERAPY 33 (7-8), A37-A38, 2022 | | 2022 |
| Oncologists Annual Meeting H Yousefi, M Momeny, Z Alishahi, A Poursheikhani, H Eyvani, ... | | 2017 |
| Dacomitinib, a pan-ErbB inhibitor, inhibits proliferation and invasion of pancreatic ductal adenocarcinoma cells F Esmaeili, M Momeny, H Yousefi, H Eyvani, Z Sabourinejad, F Barghi, ... Annals of Oncology 28, x68-x69, 2017 | | 2017 |
| EGFR BLOCKADE REVERSES CHEMORESISTANCE IN HUMAN OVARIAN CARCINOMA CELLS A POURSHEIKHANI, M MOMENY, G ZARRINRAD, H YOUSEFI, ... | | 2017 |
| 311P Blockade of vascular endothelial growth factor receptors by tivozanib inhibits growth and restores chemosensitivity in human ovarian carcinoma cells G Zarrinrad, M Momeny, Z Sabourinejad, F Moghaddaskho, H Eyvani, ... Annals of Oncology 27, ix97-ix98, 2016 | | 2016 |
